4//SEC Filing
BIOMARIN PHARMACEUTICAL INC 4
Accession 0001048477-08-000004
$BMRNCIK 0001048477operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:50 PM ET
Size
42.2 KB
Accession
0001048477-08-000004
Insider Transaction Report
Form 4
Swiedler Stuart J
SVP, Clinical Affairs
Transactions
- Sale
Common Stock
2008-01-02$36.48/sh−209$7,624→ 14,791 total - Sale
Common Stock
2008-01-02$36.30/sh−470$17,061→ 15,780 total - Sale
Common Stock
2008-01-02$36.14/sh−1,250$45,175→ 17,500 total - Sale
Common Stock
2008-01-02$36.00/sh−750$27,000→ 20,508 total - Sale
Common Stock
2008-01-02$35.96/sh−642$23,086→ 21,858 total - Sale
Common Stock
2008-01-02$36.11/sh−1,100$39,721→ 18,750 total - Sale
Common Stock
2008-01-02$36.31/sh−740$26,869→ 15,040 total - Exercise/Conversion
Common Stock
2008-01-02$6.13/sh+12,500$76,625→ 22,500 total - Sale
Common Stock
2008-01-02$35.97/sh−100$3,597→ 21,758 total - Sale
Common Stock
2008-01-02$36.32/sh−40$1,453→ 15,000 total - Sale
Common Stock
2008-01-02$36.35/sh−200$7,270→ 10,300 total - Sale
Common Stock
2008-01-02$35.99/sh−500$17,995→ 21,258 total - Sale
Common Stock
2008-01-02$36.49/sh−300$10,947→ 14,491 total - Sale
Common Stock
2008-01-02$36.05/sh−8$288→ 20,000 total - Sale
Common Stock
2008-01-02$36.10/sh−150$5,415→ 19,850 total - Sale
Common Stock
2008-01-02$36.00/sh−400$14,400→ 20,108 total - Sale
Common Stock
2008-01-02$36.50/sh−441$16,097→ 14,050 total - Exercise/Conversion
Stock Option (right to buy)
2008-01-02−12,500→ 417,733 totalExercise: $6.13From: 2005-07-07Exp: 2015-01-06→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 Trading Plan.
- [F2]Original option grant vested 6/48ths on 7/7/2005 and 1/48th on the 7th of each month thereafter.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001048477
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:50 PM ET
- Size
- 42.2 KB